Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The Centre for Statistics in Medicine (CSM) has been awarded £2.5m by Cancer Research UK to advance a programme of work for research on research, developing crucial methodology and key guidelines for excellent medical research.

The impact of research on research work is far reaching and the outcomes of this multi-tiered project will underpin the quality of future research, not only in cancer research but well beyond it.

Professor Gary Collins will lead the five-year programme grant focusing on developing methods and reporting for prognostic models and early diagnosis, particularly in artificial intelligence and machine learning. All the planned projects are all aimed at improving the quality and reliability of the cancer research literature, and thus will be of considerable practical benefit to cancer researchers (and beyond), clinicians, policy makers, and patients.

He says: “After a difficult 12 months, following the passing of long-term collaborator and founding CSM Director, Professor Doug Altman, who previously led the grant, I’m absolutely delighted that we have secured funding from Cancer Research UK to continue our programme of research to improve statistical methodology and reporting of medical research. We have an exciting programme of research, with a primary focus on improving the conduct and reporting of studies of prognosis – particularly of studies using artificial intelligence and machine learning.”

The programme of research will also foster the development of reporting guidelines to support researchers to deliver better research. Following an extensive evaluation of reporting in the published oncology literature using machine learning and artificial intelligence, a tailored version of TRIPOD will be developed, along with explicit guidance on how to use the guideline with examples of good reporting to help researchers. 

Interestingly to the project, CSM hosts the EQUATOR Network, an international initiative aiming to improve the reliability and value of published health research through transparent and accurate reporting and wider use of robust reporting guidelines.

EQUATOR will be instrumental to the dissemination of all reporting guidelines arising from this research, as well as in delivering training to researchers on all the things that ensure research is well done and well written, maximising quality and uptake by healthcare professionals and policy-makers.

Cancer Research UK stands out as one of the very few funders supporting research on research, promoting better research at the onset.

“We are incredibly grateful to CR UK for their commitment to funding research which is at the core of all other research – methodology. Very few programme grants support this type of research and recognition by this funder of the importance of methodology is refreshing and frankly, superb!”, says Professor Collins.

Find out more

CSM logo

EQUATOR Centre UK

The TRIPOD Statement was published by 13 journals and endorsed by many more, transforming the reporting of prediction modelling studies in biomedical sciences.

Funder

cancerresearchuklogo16by90a0922cb659564f3a772ff0000325351.jpg

Similar stories

New centre aims to help companies conduct more efficient trials

Botnar Main Trials

A new clinical therapeutics centre has been set up by the University of Oxford to help life sciences companies identify interventions that have the greatest potential to deliver patient benefit, and so bring down the cost of early phase clinical trials.

Cognitive–behavioural therapy consistently improves quality of life

Main Rehabilitation and self-management Research

A meta-review of the available research into cognitive behavioural therapy reveals it consistently improves health-related quality of life across different medical conditions and demographic populations.

Oxford to collaborate with Janssen to map the cellular landscape of immune mediated disorders

Main Research

The University of Oxford has entered into a strategic collaboration with Janssen Biotech, Inc., one of the Janssen Pharmaceutical Companies of Johnson & Johnson.

Versus Arthritis Foundation Fellowship awarded to Dr Kristina Zec

Awards Main

Dr Kristina Zec has been awarded a Versus Arthritis Foundation Fellowship to investigate the role of products of lipid oxidation produced by synovial macrophages in triggering articular inflammation.

Study reveals the safety of bisphosphonates in chronic kidney disease

Main

The results of an observational study published in JMBR and funded by the Health Technology Assessment Programme shows that bisphosphonate use is associated with a greater risk of chronic kidney disease progression.

WHiTE Four trial results published

Hip Main OCTRU Orthopaedics and trauma Research

The results of the WHiTE Four clinical trial for the treatment of fragility hip fractures have been published in The Bone and Joint Journal.